PrimeRFP SCOUT · Federal Contract Recompete Brief

75N94026P00062NIDDK: inflammatory and vascular diseases — Exonova Biosciences LLC

Exonova Biosciences LLC holds $550K across 3 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Dec 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Nichd

Awarding office

Exonova Biosciences LLC

Recipient

Dec 31, 2026

PoP end

$190K

Obligated

$190K

Potential

541690

NAICS

R499

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Exonova Biosciences LLC — $90

Contract facts

NONE

Contract number75N94026P00062

AgencyNational Institutes Of Health Nichd

Awarding officeNational Institutes Of Health Nichd

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentExonova Biosciences LLC

CAGE9PM49

UEIDBSRKKLNHV89

NAICS541690

PSCR499

Place of performanceBETHESDA MD

Pricing typeFirm Fixed Price

Extent competedNot Competed

Related solicitation75N94026Q00012

PoP startJan 1, 2026

PoP end (current)Dec 31, 2026

Obligated$190K

Current value$190K

Potential value$190K

NIDDK: INFLAMMATORY AND VASCULAR DISEASES SCIENTIFIC SUPPORT. SEVERABLE. is a federal NONE award for National Institutes Of Health Nichd held by Exonova Biosciences LLC. Estimated value $190K ($190K obligated). Current period of performance ends Dec 31, 2026. Last award drew 1 bidder. Place of performance: BETHESDA MD. Related solicitation 75N94026Q00012.

NIDDK: INFLAMMATORY AND VASCULAR DISEASES SCIENTIFIC SUPPORT. SEVERABLE.

Recompete timing

Public

● Expiring in 115 days

Current PoP ends Dec 31, 2026 (115 days remaining). Agencies typically plan 12–18 months ahead — at 3.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Exonova Biosciences LLC — $550K obligated across 3 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$550K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N94026P00062?

75N94026P00062 (NIDDK: inflammatory and vascular diseases) is a National Institutes Of Health Nichd award with a potential value of $190K, currently held by Exonova Biosciences LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N94026P00062?

National Institutes Of Health Nichd awarded 75N94026P00062 to Exonova Biosciences LLC (potential $190K).

Who is the incumbent on 75N94026P00062?

Exonova Biosciences LLC is the incumbent with $550K across 3 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.

When does Exonova Biosciences LLC’s 75N94026P00062 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N94026P00062 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Dec 17, 2025